HCA Healthcare Inc (NYSE: HCA) kicked off on Tuesday, up 0.05% from the previous trading day, before settling in for the closing price of $345.55. Over the past 52 weeks, HCA has traded in a range of $289.98-$417.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 6.69%. While this was happening, its average annual earnings per share was recorded 13.25%. With a float of $174.51 million, this company’s outstanding shares have now reached $249.98 million.
Let’s determine the extent of company efficiency that accounts for 316000 employees. In terms of profitability, gross margin is 50.44%, operating margin of 21.64%, and the pretax margin is 12.07%.
HCA Healthcare Inc (HCA) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Care Facilities Industry. The insider ownership of HCA Healthcare Inc is 29.12%, while institutional ownership is 65.68%. The most recent insider transaction that took place on Feb 14 ’25, was worth 3,075,240. In this transaction SVP & Chief Human Res. Officer of this company sold 9,533 shares at a rate of $322.59, taking the stock ownership to the 15,412 shares. Before that another transaction happened on Feb 14 ’25, when Company’s Officer proposed sale 9,533 for $322.59, making the entire transaction worth $3,075,238.
HCA Healthcare Inc (HCA) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 6.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.25% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.14% during the next five years compared to 16.93% growth over the previous five years of trading.
HCA Healthcare Inc (NYSE: HCA) Trading Performance Indicators
Take a look at HCA Healthcare Inc’s (HCA) current performance indicators. Last quarter, stock had a quick ratio of 0.97. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.21. Likewise, its price to free cash flow for the trailing twelve months is 15.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 21.99, a number that is poised to hit 5.78 in the next quarter and is forecasted to reach 27.96 in one year’s time.
Technical Analysis of HCA Healthcare Inc (HCA)
Looking closely at HCA Healthcare Inc (NYSE: HCA), its last 5-days average volume was 1.29 million, which is a drop from its year-to-date volume of 1.66 million. As of the previous 9 days, the stock’s Stochastic %D was 87.15%. Additionally, its Average True Range was 8.93.
During the past 100 days, HCA Healthcare Inc’s (HCA) raw stochastic average was set at 72.15%, which indicates a significant decrease from 92.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 14.73% in the past 14 days, which was lower than the 29.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $325.79, while its 200-day Moving Average is $345.80. However, in the short run, HCA Healthcare Inc’s stock first resistance to watch stands at $348.22. Second resistance stands at $350.71. The third major resistance level sits at $353.44. If the price goes on to break the first support level at $343.00, it is likely to go to the next support level at $340.27. Now, if the price goes above the second support level, the third support stands at $337.78.
HCA Healthcare Inc (NYSE: HCA) Key Stats
The company with the Market Capitalisation of 85.12 billion has total of 246,203K Shares Outstanding. Its annual sales at the moment are 70,603 M in contrast with the sum of 5,760 M annual income. Company’s last quarter sales were recorded 18,285 M and last quarter income was 1,438 M.
